Outsourcing

The countries of Central and Eastern Europe and the Commonwealth of Independent States are closing in on global pharmaceutical competition.

This article demonstrates that test results support the position of FDA on the importance of an appropriate supplier-qualification program.

The nation's healtcare system needs an overhaul, but it has to be done right.

Brief pharmaceutical news items for October 2009.

A new analysis highlights growth drivers and challenges for clinical supply-chain services.

Contract research organizations such as Covance are heading further east through Europe.

As the pharmaceutical industry moves further into Central and Eastern Europe and the Commonwealth of Independent States, several standard-setting and regulatory bodies are also increasing collaboration in the region, particularly in Russia.

This article is part of a Special Report on the Emerging Markets of The East, October 2009

Company and People Notes: Boehringer Ingelheim will acquire Wyeth's animal health business; Amsterdam Molecular Therapeutics appoints CEO; more...

Julian Mosquera, Director of LCP Consulting, advises how pharma companies can make their supply chains leaner.

Despite the economic downturn, Spain's pharmaceutical industry continues to grow - particularly when it comes to biotechnology.

Company and People Notes: Wyeth and Ambrx form development pact; Elite Pharma appoints CEO and CSO; more...

Company and People Notes: Sanofi Pasteur signs H1N1 vaccine deal with Brazilian government; Helsinn Group appoints CEO of US business; more...

Small-format packaging equipment can provide benefits to the pharmaceutical industry such as quick changeover and low tooling costs. The machines also can shorten the time it takes to bring a product to the market.

Company and People Notes: Neoprobe and Laureate Pharma form manufacturing agreement; Akela Pharma appoints CEO and chairman; more...

The US Pharmacopeial Convention (USP) and the Permanent Commission of the Pharmacopeia of the United Mexican States (FEUM) signed a memorandum of understanding (MOU) last week.

Also, Orexo and Novartis form agreement; Affitech appoints Robert Burns CEO; more...

Brief pharmaceutical news items for September 2009.

After years of promomting QbD concepts, FDA's ready to take action on nonconformers.

Contract-service providers are expanding their offerings in this slow-growth environment.

Personalized medicine and integrated healthcare delivery require new business and pricing models. This article contains bonus online-exclusive material.

Select contract manufacturing organizations roll out expansions for production of active pharmaceutical ingredients and intermediates.

As new process validation guidelines emerge, industry needs to reinvent how it releases product.

IPEC's new stability testing guide takes into account the full supply chain's storage conditions.

The author reviews the major biopharmaceutical markets' activity and predicts how the markets may evolve.